Linearity [Regulatives / Guidelines]

posted by Ohlbe – France, 2022-01-24 13:16 (378 d 16:37 ago) – Posting: # 22751
Views: 1,433

Hi John,

Does your drug show linear PK ? If not: does it show more-than-proportional increase (then the highest strength would be more sensitive to show differences in BA) or less-than-proportional increase (lowest strength would be more sensitive, giving you good arguments) ?


Complete thread:

UA Flag
 Admin contact
22,481 posts in 4,710 threads, 1,603 registered users;
30 visitors (0 registered, 30 guests [including 19 identified bots]).
Forum time: 05:53 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz